UK taps Pfiz­er over home­town GSK to sup­ply RSV vac­cine dos­es

The UK gov­ern­ment has se­lect­ed Pfiz­er to sup­ply mil­lions of res­pi­ra­to­ry syn­cy­tial virus (RSV) vac­cine dos­es, snub­bing lo­cal phar­ma com­pa­ny GSK and its com­pet­ing prod­uct …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.